The inhibition of heparanase eliminates the cleavage of HS chains and the release of bioactive molecules such as, FGFs, and VEGF, to disrupt the downstream events that are associated not only with the progression of cancer but also with cancer metastasis. Here, VEGFA is linked to cancer.